1. 06:00
  2. 07:00
  3. 08:00
  4. 09:00
  5. 10:00
  6. 11:00
  7. 12:00
  8. 13:00
  9. 14:00
  10. 15:00
  11. 16:00
  12. 17:00
  13. 18:00
  14. 19:00
  15. 20:00
  16. 21:00
  1. Foyer

  2. Room 0.94 - 0.95

  3. Auditorium

  4. Room 0.96 - 0.97

  5. Hall G1

  6. Hall F2

  7. Hall G2

  8. Hall K1

  9. Room 0.12

    1. 06:00
    2. 07:00
    3. 08:00
    4. 09:00
    5. 10:00
    6. 11:00
    7. 12:00
    8. 13:00
    9. 14:00
    10. 15:00
    11. 16:00
    12. 17:00
    13. 18:00
    14. 19:00
    15. 20:00
    16. 21:00
  1. Auditorium

    1. Plenary Session 07 - New trials update

      New trials update Plenary Session 07

      08:00 - 09:45

    2. Welcome and introduction

      Welcome and introduction

      08:30 - 08:40

    3. Plenary Session 15 - Announcement 3 best unmoderated posters

      Announcement 3 best unmoderated posters Plenary Session 15

      08:30 - 08:45

    4. Early detection of prostate cancer 40 years later. The 40th birthday of PSA


      Early detection of prostate cancer 40 years later. The 40th birthday of PSA

      08:40 - 10:30

    5. Plenary Session 16

      • Pathology in active surveillance

      Pathology in active surveillance: Update and controversies Plenary Session 16

      08:45 - 09:15

    6. Debate - Treatment of metastatic prostate cancer

      Treatment of metastatic prostate cancer Debate

      09:15 - 10:35

    7. Plenary Session 08 - Announcement 3 best unmoderated posters

      Announcement 3 best unmoderated posters Plenary Session 08

      09:45 - 10:00

    8. Multidisciplinary case discussion - Residual disease after chemotherapy in testicular cancer

      Residual disease after chemotherapy in testicular cancer Multidisciplinary case discussion

      10:30 - 11:00

    9. EU Joint Action (Innovative Partnership for Action Against Cancer IPAAC)

      EU Joint Action (Innovative Partnership for Action Against Cancer IPAAC)

      10:35 - 10:50

    10. Plenary Session 19 - Take home messages

      Take home messages Plenary Session 19

      10:50 - 11:40

    11. Multidisciplinary case discussion - Prostate cancer: From active surveillance to active treatment

      Prostate cancer: From active surveillance to active treatment Multidisciplinary case discussion

      11:00 - 12:00

    12. Plenary Session 10 - Late breaking news session

      Late breaking news session Plenary Session 10

      11:00 - 11:25

    13. Plenary Session 11 - False positives findings in uro-oncology and their clinical impact

      False positives findings in uro-oncology and their clinical impact Plenary Session 11

      11:25 - 12:05

    14. Closing remarks

      Closing remarks

      11:40 - 11:50

    15. Plenary Session 03 - Highlights in GU cancers

      Highlights in GU cancers Plenary Session 03

      12:00 - 12:40

    16. Plenary Session 12 - Oral presentation of the 6 best abstracts

      Oral presentation of the 6 best abstracts Plenary Session 12

      12:00 - 12:40

    17. Industry Session BAYER - Recent advances in sequencing strategies for advanced prostate cancer

      Recent advances in sequencing strategies for advanced prostate cancer Industry Session BAYER

      13:00 - 14:00

    18. Industry Session SANOFI - Optimizing survival in metastatic prostate cancer

      Optimizing survival in metastatic prostate cancer Industry Session SANOFI

      13:00 - 14:00

    19. Novelties in non-muscle invasive bladder cancer

      Novelties in non-muscle invasive bladder cancer

      14:00 - 15:15

    20. Plenary Session 13 - Small renal masses in patients with different comorbidity profiles

      Small renal masses in patients with different comorbidity profiles Plenary Session 13

      14:00 - 16:00

    21. Nightmare session: It could happen to you…

      Nightmare session: It could happen to you…

      15:15 - 15:45

    22. Challenge the expert

      • Complete response after neoadjuvant chemotherapy or immunotherapy
      • Histological variants in non-muscle invasive bladder cancer
      • Upper tract recurrence after cystectomy

      Challenge the expert

      16:15 - 17:30

    23. Plenary Session 14 - Combined treatment with immunotherapy

      Combined treatment with immunotherapy Plenary Session 14

      16:30 - 17:30

    24. Industry Session JANSSEN - New data in advanced prostate cancer: What does it mean for your practice?

      New data in advanced prostate cancer: What does it mean for your practice? Industry Session JANSSEN

      17:45 - 18:45

  2. Hall G2

    1. YAU Meeting - YAU Autumn Meeting

      YAU Autumn Meeting YAU Meeting

      10:00 - 12:00

    2. EAU Section Uro-Pathology (ESUP) Symposium, organized with EAU Section Urological Research (ESUR) and European Society of Pathology Uropathology Working Group - Current applications and future perspectives of liquid biopsies in Uro-Oncology

      Current applications and future perspectives of liquid biopsies in Uro-Oncology EAU Section Uro-Pathology (ESUP) Symposium, organized with EAU Section Urological Research (ESUR) and European Society of Pathology Uropathology Working Group

      13:30 - 16:30

    3. Uropathology Course - Morphologic and molecular classification of bladder cancer

      Morphologic and molecular classification of bladder cancer Uropathology Course

      16:45 - 17:45

  3. Hall K1

    1. ESU Course 01 - Oligometastases in genito urinary cancers

      Oligometastases in genito urinary cancers ESU Course 01

      09:00 - 12:00

    2. Industry Workshop FERRING - How do we maximise our window of opportunity to treat patients with NMIBC resistant to standard treatment?

      How do we maximise our window of opportunity to treat patients with NMIBC resistant to standard treatment? Industry Workshop FERRING

      12:30 - 13:30

    3. ESU Course 02 - Immunotherapy for urological tumours

      Immunotherapy for urological tumours ESU Course 02

      14:00 - 17:00

    4. ESU 2 barcodes - ESU barcode 2

      ESU barcode 2 ESU 2 barcodes

      17:00 - 18:00

  4. Room 0.12

    1. FALCON - Pelvic nodal irradiation: Any news in the the new era of imaging?

      Pelvic nodal irradiation: Any news in the the new era of imaging? FALCON

      14:00 - 16:00

  5. Hall G1

    1. ESUI Meeting - 8th Meeting of the EAU Section of Urological Imaging

      8th Meeting of the EAU Section of Urological Imaging ESUI Meeting

      08:30 - 18:00

  6. Foyer

    1. Coffee break and poster viewing

      Coffee break and poster viewing

      10:00 - 10:30

    2. Coffee break and poster viewing

      Coffee break and poster viewing

      10:30 - 11:00

    3. Lunch break and poster viewing

      Lunch break and poster viewing

      12:40 - 14:00

    4. Lunch break and poster viewing

      Lunch break and poster viewing

      12:40 - 14:00

    5. Coffee break and poster viewing

      Coffee break and poster viewing

      15:45 - 16:15

    6. Coffee break and poster viewing

      Coffee break and poster viewing

      16:00 - 16:30

  7. Room 0.94 - 0.95

    1. HOT MRI reading - Course 1 - ESU/ESUI Hands-on Training Course in Prostate MRI reading for urologist

      Course 1 - ESU/ESUI Hands-on Training Course in Prostate MRI reading for urologist HOT MRI reading

      09:30 - 13:00

  8. Room 0.96 - 0.97

    1. HOT MRI Fusion 1 - Course 1 -ESU/ESUI Hands-on Training Course in MRI Fusion biopsy

      Course 1 -ESU/ESUI Hands-on Training Course in MRI Fusion biopsy HOT MRI Fusion 1

      10:00 - 12:00

    2. HOT MRI Fusion 2 - Course 2 - ESU/ESUI Hands-on Training Course in MRI Fusion biopsy

      Course 2 - ESU/ESUI Hands-on Training Course in MRI Fusion biopsy HOT MRI Fusion 2

      14:00 - 16:00

  9. Hall F2

    1. PRIAS - PRIAS meeting

      PRIAS meeting PRIAS

      13:00 - 18:15

    2. Industry Session EPGONLINE.ORG - Are you testing? DNA repair alterations in prostate cancer care and cascade testing in family members

      Are you testing? DNA repair alterations in prostate cancer care and cascade testing in family members Industry Session EPGONLINE.ORG

      17:45 - 18:45